ADVFN Logo ADVFN

We could not find any results for:
Make sure your spelling is correct or try broadening your search.

Trending Now

Toplists

It looks like you aren't logged in.
Click the button below to log in and view your recent history.

Sign Up

Already a member? Sign in

Options Flow

Live Options Flow

Market Data
News
Trading Tools
Markets
Discover

Hot Features

Follow Feed

Connect with traders and investors in our Follow Feed community.

Options Flow

Explore comprehensive options data and use advanced filters with Options Flow.

Monitor

Organize and monitor your stock and asset watchlist with Monitor.
AI Sign In Premium IconPremium Help Menu
S&P TSX Capped Composite...
39.19
-1.33%
US Tech 100
20,596.40
-1.46%
S&P 500
5,906.94
-1.07%
US Dollar vs CAD
1.43545
-0.35%
Bitcoin
92,747.35
-0.83%
Registration Strip Icon for tools Level up your trading with our powerful tools and real-time insights all in one place.
Get Started
  1. Home
  2. Investing
  3. Stocks
  4. USA
  5. NASDAQ

  6. Sunesis Pharmaceuticals Inc (SNSS) Share Price

Sunesis Pharmaceuticals Inc

Sunesis Pharmaceuticals Inc (SNSS)

NASDAQ
5.32
0.00
(0.00%)
At close: December 30 3:00PM
Delayed by 15 minutes
5.32
0.00
( 0.00% )
After Hours: -
Delayed by 15 minutes

Real-time discussions and trading ideas: Trade with confidence with our powerful platform.

Premium

Key stats and details

Current Price
5.32
Bid
4.72
Ask
4.75
Volume
-
0.00 Day's Range 0.00
0.00 52 Week Range 0.00
Market Cap
205.485M
Previous Close
5.32
Open
-
Last Trade
Last Trade Time
-
Financial Volume
-
VWAP
-
Average Volume (3m)
-
Shares Outstanding
38,625,000
Dividend Yield
-
PE Ratio
-0.12
Earnings Per Share (EPS)
-1.32
Revenue
-
Net Profit
-51.06M

About Sunesis Pharmaceuticals Inc

Sunesis Pharmaceuticals Inc is a US-based biopharmaceutical company. It focuses on the development and commercialization of its pipeline of oncology therapeutics for the treatment of solid and hematologic cancers. The product portfolio of the company includes Vosaroxin which is an anticancer quinolo... Sunesis Pharmaceuticals Inc is a US-based biopharmaceutical company. It focuses on the development and commercialization of its pipeline of oncology therapeutics for the treatment of solid and hematologic cancers. The product portfolio of the company includes Vosaroxin which is an anticancer quinolone derivative for the treatment of acute myeloid leukemia (AML). The company's other kinase inhibitor pipeline includes TAK-580, SNS-062, and SNS-229. Further, the firm's activities include conducting research and development internally and through corporate collaborators, in-licensing and out-licensing pharmaceutical compounds and technology, conducting clinical trials and raising capital. The firm derives substantially the majority of revenue from license and collaboration agreements. Show more

Sector
Pharmaceutical Preparations
Industry
Pharmaceutical Preparations
Website
www.viracta.com
Headquarters
Wilmington, Delaware, USA
Founded
-

Ask ADVFN Intelligence (AI)

SNSS Latest News

More News

Sunesis Pharmaceuticals Reports Third Quarter 2020 Financial Results and Recent Highlights

SOUTH SAN FRANCISCO, Calif., Nov. 16, 2020 (GLOBE NEWSWIRE) -- Sunesis Pharmaceuticals, Inc. (Nasdaq: SNSS) today reported financial results for the third quarter ended September 30, 2020. Loss...

November 16 2020
GlobeNewswire Inc.

Sunesis Pharmaceuticals to Host Conference Call on November 16th to Discuss Third Quarter 2020 Financial Results and Recent H...

SOUTH SAN FRANCISCO, Calif., Nov. 09, 2020 (GLOBE NEWSWIRE) -- Sunesis Pharmaceuticals, Inc. (Nasdaq: SNSS) today announced that it will host a conference call on Monday, November 16th, 2020 at...

November 09 2020
GlobeNewswire Inc.

Sunesis Pharmaceuticals Announces Presentation of SNS-510 Preclinical Data at the 32nd EORTC-NCI-AACR Symposium on Molecular ...

SOUTH SAN FRANCISCO, Calif., Oct. 12, 2020 (GLOBE NEWSWIRE) -- Sunesis Pharmaceuticals, Inc. (Nasdaq: SNSS) today announced a poster presentation at the 32nd EORTC-NCI-AACR Symposium on...

October 12 2020
GlobeNewswire Inc.

Sunesis Pharmaceuticals Announces Participation at Upcoming Investor Conferences

SOUTH SAN FRANCISCO, Calif., Sept. 03, 2020 (GLOBE NEWSWIRE) -- Sunesis Pharmaceuticals, Inc. (Nasdaq: SNSS) today announced that the Company will present at two upcoming virtual investor...

September 03 2020
GlobeNewswire Inc.

Sunesis Pharmaceuticals Announces 1-for-10 Reverse Stock Split

SOUTH SAN FRANCISCO, Calif., Sept. 02, 2020 (GLOBE NEWSWIRE) -- Sunesis Pharmaceuticals, Inc. (Nasdaq: SNSS) today announced that it has filed a Certificate of Amendment to its Amended and...

September 02 2020
GlobeNewswire Inc.

Sunesis Pharmaceuticals Reports Second Quarter 2020 Financial Results and Recent Highlights

SOUTH SAN FRANCISCO, Calif., Aug. 11, 2020 (GLOBE NEWSWIRE) -- Sunesis Pharmaceuticals, Inc. (Nasdaq: SNSS) today reported financial results for the second quarter ended June 30, 2020. Loss from...

August 11 2020
GlobeNewswire Inc.

Sunesis Pharmaceuticals to Host Conference Call on August 11th to Discuss Second Quarter 2020 Financial Results and Recent Hi...

SOUTH SAN FRANCISCO, Calif., Aug. 04, 2020 (GLOBE NEWSWIRE) -- Sunesis Pharmaceuticals, Inc. (Nasdaq: SNSS) today announced that it will host a conference call on Tuesday, August 11th, 2020 at...

August 04 2020
GlobeNewswire Inc.

Sunesis Announces Pricing of $12 Million Offering of Common Stock

SOUTH SAN FRANCISCO, Calif., July 29, 2020 (GLOBE NEWSWIRE) -- Sunesis Pharmaceuticals, Inc. (Nasdaq: SNSS) today announced the pricing of an underwritten public offering of 52,173,913 shares of...

July 29 2020
GlobeNewswire Inc.

Sunesis Announces Proposed Public Offering of Common Stock

SOUTH SAN FRANCISCO, Calif., July 28, 2020 (GLOBE NEWSWIRE) -- Sunesis Pharmaceuticals, Inc. (Nasdaq: SNSS) today announced that it intends to offer and sell, subject to market and other...

July 28 2020
GlobeNewswire Inc.

Sunesis Pharmaceuticals Provides Corporate Update

SOUTH SAN FRANCISCO, Calif., July 07, 2020 (GLOBE NEWSWIRE) -- Sunesis Pharmaceuticals, Inc. (Nasdaq: SNSS) today announced a reduction in workforce of approximately 30% of its head count to...

July 07 2020
GlobeNewswire Inc.
PeriodChangeChange %OpenHighLowAvg. Daily VolVWAP
10000000CS
40000000CS
120000000CS
260000000CS
520000000CS
1560000000CS
2600000000CS

SNSS - Frequently Asked Questions (FAQ)

What is the current Sunesis Pharmaceuticals share price?
The current share price of Sunesis Pharmaceuticals is US$ 5.32
How many Sunesis Pharmaceuticals shares are in issue?
Sunesis Pharmaceuticals has 38,625,000 shares in issue
What is the market cap of Sunesis Pharmaceuticals?
The market capitalisation of Sunesis Pharmaceuticals is USD 205.49M
What is the 1 year trading range for Sunesis Pharmaceuticals share price?
Sunesis Pharmaceuticals has traded in the range of US$ 0.00 to US$ 0.00 during the past year
What is the PE ratio of Sunesis Pharmaceuticals?
The price to earnings ratio of Sunesis Pharmaceuticals is -0.12
What is the reporting currency for Sunesis Pharmaceuticals?
Sunesis Pharmaceuticals reports financial results in USD
What is the latest annual profit for Sunesis Pharmaceuticals?
The latest annual profit of Sunesis Pharmaceuticals is USD -51.06M
What is the registered address of Sunesis Pharmaceuticals?
The registered address for Sunesis Pharmaceuticals is CORPORATION TRUST CENTER, 1209 ORANGE ST, WILMINGTON, DELAWARE, 19801
What is the Sunesis Pharmaceuticals website address?
The website address for Sunesis Pharmaceuticals is www.viracta.com
Which industry sector does Sunesis Pharmaceuticals operate in?
Sunesis Pharmaceuticals operates in the PHARMACEUTICAL PREPARATIONS sector

Movers

View all
  • Most Active
  • % Gainers
  • % Losers
SymbolPriceVol.
APMAptorum Group Ltd
US$ 3.43
(153.14%)
2.05M
BDMDBaird Medical Investment Holdings Ltd
US$ 1.36
(29.52%)
26.27k
VSTMVerastem Inc
US$ 4.37
(19.07%)
933.22k
ASNSActelis Networks Inc
US$ 1.53
(17.69%)
385.48k
CETXCemtrex Inc
US$ 3.66
(16.93%)
455.76k
SGMOSangamo Therapeutics Inc
US$ 0.9995
(-57.29%)
10.48M
VRPXVirpax Pharmaceuticals Inc
US$ 0.3461
(-23.72%)
720.3k
WATTEnergous Corporation
US$ 2.21
(-16.60%)
6.04M
RGFReal Good Food Company Inc
US$ 0.2705
(-15.71%)
67.31k
RAYRaytech Holding Ltd
US$ 1.21
(-12.32%)
7.88k
EYENEyenovia Inc
US$ 0.1257
(10.94%)
20.98M
XTIAXTI Aerospace Inc
US$ 0.0414
(4.81%)
11.78M
SGMOSangamo Therapeutics Inc
US$ 0.9995
(-57.29%)
10.48M
AIEVThunder Power Holdings Inc
US$ 0.45
(0.02%)
8.3M
GERNGeron Corp
US$ 3.38
(-0.59%)
7.74M

SNSS Discussion

View Posts
NASDAQ2020 NASDAQ2020 3 years ago
HammerTime !

GLTY SNSS-AMC
👍️0
NASDAQ2020 NASDAQ2020 4 years ago
Hammertime SNSS
👍️0
Dspetry Dspetry 4 years ago
https://www.prnewswire.com/news-releases/viracta-therapeutics-announces-closing-of-merger-with-sunesis-pharmaceuticals-and-65m-private-placement-301234939.html
👍️0
ClayTrader ClayTrader 4 years ago
* * $SNSS Video Chart 02-24-2021 * *

Link to Video - click here to watch the technical chart video

👍️0
Jaydixson1 Jaydixson1 4 years ago
Why would anyone sell while it’s going up
👍️0
ClayTrader ClayTrader 4 years ago
* * $SNSS Video Chart 02-23-2021 * *

Link to Video - click here to watch the technical chart video

👍️0
Jaydixson1 Jaydixson1 4 years ago
Looking good
👍️0
MAKESOME79 MAKESOME79 4 years ago
$SNSS Two things are happening. 1.) #StockTrading higher after #stock upgrade from Perform to Outperform and a price target of $12 per share. 2.) Reverse Merger with @ViractaT announced the parties entered into a definitive merger agreement. This Reverse stock split. The split funny enough says 3-1 and 6-1. That means our shares are going to increase. Because a true reverse split is 1-3 or 1-6. Did you notice the difference in how it was typed. I'm thinking we will get either 3x the shares we have now of the new symbol $Virx. What are you thought on this. Second they say the have to close above 4.00 before the split. I was looking at the sec doc and was going to post the link and forgot which one it is but it is in there.
👍️0
BoilerRoom BoilerRoom 4 years ago
Guarantee it bud
👍️0
crudeoil24 crudeoil24 4 years ago
$6.00+ by closing bell. Massive volume/fomo/momo.

SNSS
👍️0
BoilerRoom BoilerRoom 4 years ago
I got in at $4.50
👍️0
crudeoil24 crudeoil24 4 years ago
I got in @ 4.11 way after opening bell.
👍️0
BoilerRoom BoilerRoom 4 years ago
$SNSS my volume scanner picked this up pre market. Easy mover
👍️0
crudeoil24 crudeoil24 4 years ago
Yup! SNSS going gangbusters!
👍️0
BoilerRoom BoilerRoom 4 years ago
$SNSS happy to get Money back here I lost on a OTC stock last week. Looking great!
👍️0
BoilerRoom BoilerRoom 4 years ago
Yes, going run today
👍️0
crudeoil24 crudeoil24 4 years ago
SNSS > 16M float > Super low trading float!
👍️0
crudeoil24 crudeoil24 4 years ago
Sunesis Pharmaceuticals shares are trading higher after Oppenheimer upgraded the stock from Perform to Outperform and announced a price target of $12 per share.

Feb 23, 2021 8:03a ETBenzinga Stock Analysis
👍️0
BoilerRoom BoilerRoom 4 years ago
$SNSS Running
👍️0
mick mick 4 years ago
Sunesis Pharmaceutic (SNSS)
3.7 ? -0.07 (-1.86%)
Volume: 261,758 @02/19/21 5:43:36 PM EST
Bid Ask Day's Range
3.62 3.9 3.65 - 3.82
SNSS Detailed Quote
👍️0
mick mick 4 years ago
https://otcbb.swingtradebot.com/equities/SNSS

N.Y. , NASDAQ
https://swingtradebot.com/equities/SNSS
👍️0
stocktalk211 stocktalk211 4 years ago
Alert From Transparent Traders

SNSS

ENTRY $3.20

STOP $2.99

TARGET $6.22


$1 30 day trial Transparent Traders Blackbox
👍️0
stocktalk211 stocktalk211 4 years ago
Alert From Transparent Traders

SNSS

ENTRY $3.20

STOP $2.99

TARGET $6.22


$1 30 day trial Transparent Traders Blackbox
👍️0
mick mick 4 years ago
https://pennystocks.news/otc/?symbol=SNSS
👍️0
mick mick 4 years ago
Sunesis Pharmaceutic (SNSS)
1.84 ? 0.05 (2.79%)
Volume: 619,300 @12/14/20 5:53:09 PM EST
Bid Ask Day's Range
1.79 1.84 1.74 - 1.88
SNSS Detailed Quote
👍️0
John_Langston John_Langston 4 years ago
SNSS Is getting on my last nerve.

When $#IT like NKLA is trading at over $17 dollars a share.
👍️0
mick mick 4 years ago
Sunesis Pharmaceutic (SNSS)
1.82 ? 0.09 (5.20%)
Volume: 1,703,641 @12/07/20 1:07:27 PM EST
Bid Ask Day's Range
1.82 1.85 1.73 - 1.91
SNSS Detailed Quote
👍️0
John_Langston John_Langston 4 years ago
SMDH

That's an acronym, not a ticker. LOL
👍️0
ClayTrader ClayTrader 4 years ago
* * $SNSS Video Chart 11-30-2020 * *

Link to Video - click here to watch the technical chart video

👍️0
IB_ IB_ 4 years ago
She told me to sell SNSS at $2.03 and against my "hold till I'm dead nature" I listened :)

IB_
👍️0
John_Langston John_Langston 4 years ago
She F.ed you twice.
👍️0
IB_ IB_ 4 years ago
The CEO's MoM !!!!!!!!!!!!!

LoL,

IB_ :)
👍️0
John_Langston John_Langston 4 years ago
It’s 10:30 and the Looney Tunes hour is over. lol
👍️0
John_Langston John_Langston 4 years ago
NASDAQ and who else? lol
👍️0
IB_ IB_ 4 years ago
I made a few calls !!!!!!!!!!!!!!!!!!!!!!!

LoL LoL

IB_ :)
👍️0
John_Langston John_Langston 4 years ago
Well that explains everything.
👍️0
IB_ IB_ 4 years ago
I sold my SNSS today at $2.03 !!!!!!!!!!!!!!!!!!!!!!!!!!!!!!

IB_ :)
👍️0
John_Langston John_Langston 4 years ago
Great news.

It’s about time.
👍️0
Techmozz Techmozz 4 years ago
https://finance.yahoo.com/news/sunesis-pharmaceuticals-viracta-therapeutics-announce-123000277.html

👍️0
mick mick 4 years ago
Sunesis Pharmaceutic (SNSS)
1.26 ? -0.04 (-3.08%)
Volume: 499,222 @11/17/20 3:44:26 PM EST
Bid Ask Day's Range
1.25 1.26 1.2 - 1.26
SNSS Detailed Quote
👍️0
mick mick 4 years ago
I DID NOT SEE IT MY FRIEND 'Sunesis Pharmaceuticals (SNSS)'
👍️0
John_Langston John_Langston 4 years ago
A great ER and the Robinhood DAs are selling.

I don't see this going up until the acquisition news is released and then the PPS will look like a Space X launch.
👍️0
John_Langston John_Langston 4 years ago
I thought Sunesis was releasing the ER today.
👍️0
mick mick 4 years ago
Sunesis Pharmaceutic (SNSS)
1.1975 ? 0.0325 (2.79%)
Volume: 305,127 @10/30/20 9:59:17 AM EDT
Bid Ask Day's Range
1.19 1.2 1.17 - 1.26
SNSS Detailed Quote
👍️0
John_Langston John_Langston 4 years ago
I added more yesterday.
👍️0
mick mick 4 years ago
Sunesis Pharmaceutic (SNSS)
1.2 ? 0.03 (2.56%)
Volume: 1,607,341 @10/29/20 6:11:48 PM EDT
Bid Ask Day's Range
1.2 1.23 1.12 - 1.24
SNSS Detailed Quote
👍️0
spacehc spacehc 4 years ago
...add ingrediency ...blend...cold down....freeze.....warm up and.........KA-BAM

Thanks to all!
👍️0
mick mick 4 years ago
Sunesis Pharmaceuticals Announces Presentation of SNS-510 Preclinical Data at the 32nd EORTC-NCI-AACR Symposium on Molecular ... GlobeNewswire Inc. - 10/12/2020 7:00:10 AM
Current Report Filing (8-k) Edgar (US Regulatory) - 9/18/2020 4:14:28 PM
Sunesis Pharmaceuticals Announces Participation at Upcoming Investor Conferences GlobeNewswire Inc. - 9/3/2020 7:00:10 AM
👍️0
mick mick 4 years ago
Sunesis Pharmaceutic (SNSS)
1.45 ? 0.15 (11.54%)
Volume: 2,006,251 @10/23/20 7:57:59 PM EDT
Bid Ask Day's Range
1.38 2.4 1.28 - 1.55
SNSS Detailed Quote
👍️0
John_Langston John_Langston 4 years ago
More like Rogersed.

The Robinhood investors buy up over one tenth of the float today at $1.45 just to sell it at $1.35 next week.

And they keep doing it week after week.

SMH
👍️0

Your Recent History

NASDAQ
SNSS
Sunesis Pharmaceuticals
Delayed Upgrade Clock
ADVFN Logo
InvestorsHub

Canada
Company
Business
Popular
Get The App
App Store
Google Play

Support: +44 (0) 203 8794 460 | support@advfn.com

By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions

© 2024 ADVFN PLC - All Rights Reserved

Go Ad-Free

Subscribe to Ad free and enjoy an ad-free experience

No Ads

Try Now

Keep the Ads